| Sector |
Trading
|
Compare with Sector peers |
| Industry |
Trading
|
Compare with Industry peers |
| Website | http://www.medicointercontinental.com | |
| Market Cap | 86.68 Cr. | |
| Enterprise Value(EV) | 82.05 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 3.46 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | 25.04 | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 37.14 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 21.98 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 3.94 | Calculated using Price: 86.68 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 1.00 Cr. | 10,000,000 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| The company is a dynamic business organization operating in the field of financing, trading and investment in shares and securities. | ||
| 1 Day |
|
-0.47% |
| 1 Week |
|
-3.57% |
| 1 Month |
|
-2.46% |
| 3 Month |
|
+22.36% |
| 6 Month |
|
+37.48% |
| 1 Year |
|
+45.10% |
| 2 Year |
|
+231.77% |
| 5 Year |
|
+452.60% |
| 10 Year |
|
| 5 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 0.90 | 20.24 | 45.48 | 32.41 | 27.96 | |
| Return on Capital Employed (%) | 1.41 | 28.42 | 36.08 | 25.00 | 25.69 | |
| Return on Assets (%) | 0.76 | 11.32 | 10.44 | 7.73 | 9.91 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 3 | 4 | 6 | 10 | 13 | 14 | |
| Non Curr. Liab. | 0 | 13 | 7 | 6 | 6 | ||
| Curr. Liab. | 1 | 5 | 17 | 15 | 13 | 13 | |
| Minority Int. | |||||||
| Equity & Liab. | 4 | 9 | 36 | 31 | 32 | 45 | |
| Non Curr. Assets | 2 | 1 | 2 | 3 | 4 | 4 | |
| Curr. Assets | 2 | 8 | 34 | 28 | 28 | 41 | |
| Misc. Exp. not W/O | |||||||
| Total Assets | 4 | 9 | 36 | 31 | 32 | 45 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 10 | 82 | 70 | 74 | 62 | ||
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Income | 0 | 10 | 82 | 70 | 75 | 62 | |
| Total Expenditure | 0 | -9 | -78 | -65 | -69 | -56 | |
| PBIDT | 0 | 1 | 4 | 5 | 5 | 6 | |
| Interest | 0 | -1 | -1 | -1 | -1 | ||
| Depreciation | 0 | 0 | 0 | 0 | |||
| Taxation | 0 | 0 | -1 | -1 | -1 | -1 | |
| Exceptional Items | |||||||
| PAT | 0 | 1 | 2 | 3 | 3 | 3 | |
| Minority Interest | |||||||
| Share Associate | |||||||
| Other Related Items | |||||||
| Consolidated Net Profit | 0 | 1 | 2 | 3 | 3 | 3 | |
| Adjusted EPS | 0 | 2 | 7 | 8 | 10 | 9 |
| Particulars | 5 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 1 | -14 | 6 | 4 | |
| Cash Fr. Inv. | -4 | -1 | -1 | |||
| Cash Fr. Finan. | 0 | 17 | -5 | -1 | ||
| Net Change | 0 | 1 | 0 | 0 | 1 | |
| Cash & Cash Eqvt | 0 | 1 | 1 | 1 | 2 |
|
Wed, 15 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication We hereby wish to inform you that the unaudited financial results (Standalone & Consolidated) for the quarter and nine months ended 31st December 2022 were approved at the meeting of Board of Directors held on Tuesday 14th February 2023. In continuation to the same the newspaper clipping duly published in English and Gujarati Newspaper is enclosed herewith. |
|
Tue, 14 Feb 2023
Board Meeting Outcome for Board Meeting And Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation 2015. Pursuant to provisions of Regulation 30 and 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that the Board of Directors of the Company at its meeting held today i.e. February 14 2023 inter alia considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31 2022 along with Limited Review Report issued by M/s. V Goswami & Co Statutory Auditors of the Company.Further please find enclosed Unaudited Standalone and Consolidated Financial Results along with Limited Review Report for the quarter and nine months ended on December 31 2022 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.comThe Board Meeting of the Company commenced at 12:30 PM and concluded at 01:30 PM. |
|
Tue, 14 Feb 2023
Results - Financial Results For Quarter And Nine Months Ended On 31St December 2022 Pursuant to provisions of Regulation 30 and 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that the Board of Directors of the Company at its meeting held today i.e. February 14 2023 inter alia considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31 2022 along with Limited Review Report issued by M/s. V Goswami & Co Statutory Auditors of the Company. Further please find enclosed Unaudited Standalone and Consolidated Financial Results along with Limited Review Report for the quarter and nine months ended on December 31 2022 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 12:30 PM and concluded at 01:30 PM. |
| Tue, 21 Mar 2023 |
High Delivery Percentage
|
Opening at High
|
Making Higher Highs for 3 days
|
High Increase in 1 Month
|
High Increase in 3 Months
|
Equities
M.F.
Sectors